0
0
Read Time:11 Second
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated February 28, 2026, titled “Receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for the Desmopressin Acetate Injection USP”. |SUBJECT: Press Release
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %